Abnormal AR functions, such as functional activation, are increasingly recognized in prostate cancer development and progression, with large bodies of evidence indicating that AR activities and levels are precisely modulated by many cofactors at both transcriptional and post-translational levels. The gene discussed is AR; the disease is Familial prostate cancer.